News Updates
More Articles
- Solving the Challenge of Limited Data: Bayesian Statistics to the Rescue in Rare Disease Drug Development
- The Female Data Deficit: How Drug Development Still Fails Women
- China’s Out-Licensing Deals Bear Fruit in 2025
- From Paper to Digital: The Evolution of Electronic Product Information and the LatAm Playbook Experience
- The Hidden Governance Gap in Modern Clinical Trials
Addressing Inequity: Embedding Inclusion and Diversity in UK Clinical Trials
This article explores current clinical trial representation and inclusion initiatives led by the Health Research Authority (HRA) and Medicines & Healthcare products Regulatory Agency (MHRA) in the UK.
×
